PROVIDED BY CNNNEXT.COM
"Federal regulators this month opened a new era in the treatment of a deadly liver virus that infects three to five times more people than HIV.
Now the question is: Who will get access to the new drug for hepatitis C, and when? The drug sofosbuvir (brand name Sovaldi) will cost $1,000 per pill.
A typical course of treatment will last 12 weeks and run $84,000, plus the cost of necessary companion drugs.
Some patients may need treatment for twice as long."
Like Us on Facebook: www.facebook.com/CNNNEXT
Follow Us on Twitter: www.twitter.com/CNNNEXT
